Setting new standards in information exchange for the pharmaceutical and biotech industry

Who Should Attend

Attendee Breakdown

The program is designed for Out-of-the-box thinkers determined to make clinical trials more affordable, efficient, with higher quality data and a far better experience for patients.

Breakdown of titles from DPharm: Disruptive Innovations US

DpharmE who should attend graph

This conference is also of interest to Innovative Clinical Technology & Service Companies as well as Healthcare Investors.

Hear from some of last year’s attendees: